Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma.
Neuro-oncology advances（2021）
摘要
Our findings highlight the critical role of optimally designed phase II trials in informing drug development for GBM.
更多查看译文
关键词
clinical trials,drug development,glioblastoma,glioma,phase II,phase III,trial design
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要